Form 4: Inari Medical's Chief Medical Officer, Thomas Tu, Reports Stock Option Exercises

Sentiment:

SEC Form 4 Filing


Thomas Tu, Chief Medical Officer of Inari Medical, exercised stock options at two different prices, resulting in the acquisition of 148,004 shares of common stock.

Summary

  • On February 10, 2025, Thomas Tu, the Chief Medical Officer of Inari Medical, Inc., executed stock options.
  • He exercised options to acquire 139,584 shares of common stock at a price of $0.4569 per share.
  • Additionally, he exercised options to acquire 8,420 shares of common stock at a price of $6.4546 per share.
  • Following these transactions, Mr. Tu directly owns 471,361 shares of Inari Medical common stock.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing. It doesn't inherently convey positive or negative sentiment about the company's performance or prospects.

Industry Context

This Form 4 filing is a routine disclosure related to insider transactions and provides transparency to the market regarding the actions of Inari Medical's Chief Medical Officer.

Stakeholder Impact

  • The stock option exercises may have a minor dilutive effect on existing shareholders.

Key Dates

DateDescription
July 1, 2023Date when some of the stock options became vested and exercisable.
January 1, 2024Date when some of the stock options became vested and exercisable.
01/17/2029Expiration date of some of the stock options.
04/23/2029Expiration date of some of the stock options.
02/10/2025Date of the stock option exercises.
02/12/2025Date of the signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.